RefleXion Medical Revenue and Competitors
Estimated Revenue & Valuation
- RefleXion Medical's estimated annual revenue is currently $92.6M per year.
- RefleXion Medical received $100.0M in venture funding in April 2018.
- RefleXion Medical's estimated revenue per employee is $313,750
- RefleXion Medical's total funding is $365.1M.
Employee Data
- RefleXion Medical has 295 Employees.
- RefleXion Medical grew their employee count by -5% last year.
RefleXion Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CTO | Reveal Email/Phone |
2 | VP Regulatory Affairs | Reveal Email/Phone |
3 | VP Operations & Service | Reveal Email/Phone |
4 | VP Product Engineering | Reveal Email/Phone |
5 | VP Service & Support | Reveal Email/Phone |
6 | VP, Head Legal | Reveal Email/Phone |
7 | SVP Research and Development | Reveal Email/Phone |
8 | VP Quality Affairs | Reveal Email/Phone |
9 | VP Accounting & Controller | Reveal Email/Phone |
10 | VP Marketing | Reveal Email/Phone |
RefleXion Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2328.2M | 10903 | 6% | $4.9M | N/A |
What Is RefleXion Medical?
RefleXion Medical is on a mission to create a new cancer treatment modality through biological guidance. By leveraging positron emission tomography (PET) in a novel way, RefleXion's patented technology causes tumors to continuously signal their location during treatment, potentially revolutionizing cancer care. We're passionately committed to making dramatic changes to cancer care, and we believe that small, lean teams of brilliant people are the only way to do that. We need teammates with both the foresight and experience to avoid roadblocks, and the drive and creativity to steer around those that inevitably appear. We seek those who will unabashedly and relentlessly help us create a new modality in cancer care. If you are bold and inventive - we want you. If you combine passion with experience - we want you. If you embrace iteration and constant learning - we want you. Come and join a company on an incredible and meaningful mission. See our website's Careers Page.
keywords:Biotechnology,Cleantech,Hardware,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals,Wind Power
$365.1M
Total Funding
295
Number of Employees
$92.6M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RefleXion Medical News
4) The $80m venture financing of RefleXion Medical by Ally Bridge Group,Ascension Health Ventures,Catalio Capital Management,Hillenbrand...
Medical Devices industry cross border deals total $1.3bn globally in March ... Partners $80m venture financing deal with RefleXion Medical...
RefleXion is a privately-held company developing the first biology-guided radiotherapy system, a significant change in strategy from single...
11 Shares Email Facebook Twitter LinkedIn After receiving U.S. Food and Drug Administration clearance for treatment pertaining to its RefleXion X1 machine, therapeutic oncology company RefleXion Medical has closed on a $100 million equity financing. Subscribe to the Crunchbase Daily Public Se ...
RefleXion Medical, a Hayward, Calif.-based therapeutic oncology company using biology-guided radiotherapy (BgRT) for all stages of cancer, closed a $100m equity financing. The round was led by Public Sector Pension Investment Board (PSP Investments), with participation from existing investors, ...
Other Companies in Hayward
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $78.8M | 365 | 28% | $668M |
#2 | $134.4M | 391 | 8% | N/A |
#3 | $35M | 391 | 0% | N/A |
#4 | $88.7M | 394 | 9% | N/A |
#5 | $86.3M | 460 | 8% | N/A |
RefleXion Medical Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-04-04 | $11.6M | A | Sofinnova Partners | Article |
| 2016-04-15 | $46.0M | B | KCK Group | Article |
| 2016-07-20 | $52.0M | B | KCK Group | Article |
| 2018-04-05 | $100.0M | C | The Rise Fund | Article |